ZIIHERA
NDC 68727-950, zanidatamab-hrii, injection, powder, lyophilized, for solution, from Jazz Pharmaceuticals, Inc..
- Product NDC
- 68727-950
- Status
- Listed
- Labeler
- Jazz Pharmaceuticals, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761416
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68727-950 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZANIDATAMAB50 mg/mL
Pharmacologic classes
Bispecific HER2-directed Antibody [EPC]; HER2-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68727-950-02 | 68727095002 | 2 VIAL, SINGLE-DOSE in 1 CARTON (68727-950-02) / 6 mL in 1 VIAL, SINGLE-DOSE (68727-950-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ae5d9425-fae5-4541-a158-150998343348Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68727-950
Use it
Look up 68727-950 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68727-950 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68727-950. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.